Get the Stockscreener App
11.10
1.94%
-0.22
After Hours:
11.80
0.70
+6.31%
Surrozen Inc stock is traded at $11.10, with a volume of 12,756.
It is down -1.94% in the last 24 hours and down -22.00% over the past month.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
See More
Previous Close:
$11.32
Open:
$11.59
24h Volume:
12,756
Relative Volume:
0.30
Market Cap:
$36.07M
Revenue:
-
Net Income/Loss:
$-53.45M
P/E Ratio:
-0.5113
EPS:
-21.71
Net Cash Flow:
$-31.81M
1W Performance:
-8.04%
1M Performance:
-22.00%
6M Performance:
+53.10%
1Y Performance:
+25.42%
1-Day Range:
$11.10
$11.89
1-Week Range:
$10.63
$13.34
52-Week Range:
$5.9999
$18.17
Surrozen Inc Stock (SRZN) Company Profile
Name
Surrozen Inc
Sector
Industry
Phone
650-475-2820
Address
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Compare SRZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
11.10 | 36.07M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
481.16 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.07 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
657.97 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
278.25 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
119.94 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Initiated | H.C. Wainwright | Buy |
| Jan-03-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Sep-15-21 | Initiated | Guggenheim | Buy |
| Sep-07-21 | Initiated | Stifel | Buy |
Surrozen Inc Stock (SRZN) Latest News
HC Wainwright Predicts Surrozen FY2024 Earnings - Defense World
Surrozen (NASDAQ:SRZN) Research Coverage Started at HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Surrozen (SRZN) with Buy Recommendation - MSN
This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
HC Wainwright Initiates Coverage on Surrozen With Buy Rating, $32 Price Target -January 30, 2025 at 08:15 am EST - Marketscreener.com
H.C. Wainwright sets $32 target on Surrozen stock with Buy rating - Investing.com
(SRZN) Trading Advice - Stock Traders Daily
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Shares in Surro - GuruFocus.com
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Yahoo Finance
(SRZN) Trading Report - Stock Traders Daily
Financial Analysis: Recursion Pharmaceuticals (NASDAQ:RXRX) versus Surrozen (NASDAQ:SRZN) - Defense World
Surrozen exec vice president sells $14,642 in stock - Investing.com
Surrozen exec vice president sells $14,642 in stock By Investing.com - Investing.com UK
Surrozen's CFO and COO sells $20,513 in stock - Investing.com
Surrozen's CFO and COO sells $20,513 in stock By Investing.com - Investing.com UK
Surrozen (NASDAQ:SRZN) Upgraded by Guggenheim to “Buy” Rating - Defense World
Surrozen stock soars to 52-week high, hits $16.35 - Investing.com
(SRZN) Investment Analysis and Advice - Stock Traders Daily
Financial Review: Surrozen (NASDAQ:SRZN) & Vericel (NASDAQ:VCEL) - Defense World
Learn to Evaluate (SRZN) using the Charts - Stock Traders Daily
When the Price of (SRZN) Talks, People Listen - Stock Traders Daily
Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky - Simply Wall St
Contrasting Vigil Neuroscience (NASDAQ:VIGL) and Surrozen (NASDAQ:SRZN) - Defense World
Surrozen, Inc.: Q3 2024 Earnings Overview - TipRanks
Trading (SRZN) With Integrated Risk Controls - Stock Traders Daily
Alyeska Investment Group L.P. Expands Portfolio with Surrozen In - GuruFocus.com
Surrozen (NASDAQ:SRZN) Stock Price Down 7% – Here’s Why - Defense World
Stonepine Capital Management, LLC Increases Stake in Surrozen Inc - GuruFocus.com
Goldman Sachs Group Inc's Strategic Investment in Surrozen Inc - GuruFocus.com
Surrozen to Present at Upcoming Healthcare Investor Conferences - The Manila Times
Surrozen (SRZN) to Present at Guggenheim and Stifel Healthcare Conferences | SRZN Stock News - StockTitan
Surrozen Provides Third Quarter 2024 Financial Results and Business Update - ForexTV.com
(SRZN) Trading Signals - Stock Traders Daily
Surrozen partners with TCGFB for lung disease therapy By Investing.com - Investing.com Canada
Surrozen partners with TCGFB for lung disease therapy - Investing.com India
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - The Manila Times
The Column Group's biotech taps Surrozen for lung disease research pact - Fierce Biotech
StemPoint Capital LP Increases Stake in Surrozen Inc - GuruFocus.com
Trend Tracker for (SRZN) - Stock Traders Daily
Surrozen (NASDAQ:SRZN) Trading Up 4.3% – Here’s What Happened - Defense World
How To Trade (SRZN) - Stock Traders Daily
This Week's Bay Area Deal Sheet (October 10, 2024) - Bisnow
Surrozen extends South San Francisco headquarters lease By Investing.com - Investing.com Australia
Surrozen extends South San Francisco headquarters lease - Investing.com India
187,206 Shares in Surrozen, Inc. (NASDAQ:SRZN) Purchased by Nantahala Capital Management LLC - Defense World
Stonepine Capital Management LLC Invests $724,000 in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
CVI Holdings LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
Column Group LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZNW) - Defense World
Boehringer Ingelheim to advance SZN-413 for retinal diseases - BioWorld Online
Patrick Brennan joins Selective Insurance as CFO - Reinsurance News
Surrozen and Boehringer Ingelheim advance SZN-413 development By Investing.com - Investing.com South Africa
Surrozen Inc Stock (SRZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):